申请人:West Laboratories, Inc.
公开号:US04155874A1
公开(公告)日:1979-05-22
A new group of compounds, generically classed as phenothiazinyl sulfides, are described having the formula: ##STR1## wherein n is 1 or 2, x and/or y and/or z represent 0, 1 or 2; R.sub.1 may be H, alkyl, aryl, alkaryl, acyl, haloacyl and biologically activating aminoalkyl groups known in the medicinal arts, such as --(CH.sub.2).sub.3 --N(CH.sub.3).sub.2, ##STR2## and -[2-(1-methyl-2-piperidyl)ethyl]; and R.sub.2 and/or R.sub.3 and/or R.sub.4 and/or R.sub.5 and/or R.sub.6 and/or R.sub.7 represent H, OH, Cl, Br, F, CF.sub.3, SH, NO.sub.2, CN, COOH, alkyl, alkoxy, sulfamoyl, dimethylsulfamoyl, dimethyl amino, aryl, alkaryl, acyl, aryloxy, methyl sulfonyl, methyl thio, and -S-phenothiazinyl substitutents; and as charge-transfer complexes of iodine therewith in which the number of moles of iodine associated with the molecule equals 1.5 (range 0.75 to 3.0) times the number of phenothiazinyl groups in the molecule. Methods for the preparation of the compounds are described. The phenothiazinyl sulfides appear to be active in the same industrial and biological applications as phenothiazine and its corresponding derivatives, and show distinctive activity in various uses and as charge-transfer complexes of novel electrochemical properties as illustrated, in-vitro, in combination with iodine as a cathode material.
一种新的化合物群,通常分类为苯并
噻嗪基
硫醚,其
化学式如下:##STR1## 其中n为1或2,x和/或y和/或z代表0、1或2;R.sub.1可能是H、烷基、芳基、烷芳基、酰基、卤代酰基和在医药领域已知的
生物活性
氨基烷基,例如--(CH.sub.2).sub.3--N(CH.sub.3).sub.2,##STR2## 和-[2-(1-甲基-2-
哌啶基)乙基];R.sub.2和/或R.sub.3和/或R.sub.4和/或R.sub.5和/或R.sub.6和/或R.sub.7代表H、OH、Cl、Br、F、CF.sub.3、SH、NO.sub.2、CN、COOH、烷基、烷氧基、磺酰胺基、二甲基磺酰胺基、
二甲胺基、芳基、烷芳基、酰基、芳氧基、甲基磺酰基、甲
硫基和-S-苯并
噻嗪基取代基;以及与
碘形成的电荷转移复合物,其中与分子关联的
碘的摩尔数等于分子中苯并
噻嗪基的数量的1.5倍(范围为0.75至3.0倍)。描述了制备这些化合物的方法。苯并
噻嗪基
硫醚似乎在工业和
生物应用中与苯并
噻嗪及其相应衍
生物具有相同的活性,并且在各种用途和与
碘结合作为阴极材料的新颖电
化学性质的电荷转移复合物中显示出独特的活性,如在体外实验中所示。